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Lanthanum carbonate (LC) is an oral phosphate binder to prevent hyperphosphatemia for patients undergoing dialysis. Recently, lanthanum‐deposited cases in the stomach have been reported (Table [1](#ccr31989-tbl-0001){ref-type="table"}).[1](#ccr31989-bib-0001){ref-type="ref"} On endoscopy, such deposits are recognized as minute whitish granules within mucosa (Figure [1](#ccr31989-fig-0001){ref-type="fig"}A). Lanthanum deposition in patients taking LC is diagnosed based on detection of macrophages containing foreign body in the lamina propria (Figure [1](#ccr31989-fig-0001){ref-type="fig"}B). Quantitative analysis of elemental composition by electron probe microanalysis confirms both lanthanum and phosphorus (Figure [1](#ccr31989-fig-0001){ref-type="fig"}C). Macrophages generally can be divided into pro‐inflammatory type M1 and anti‐inflammatory type M2.[2](#ccr31989-bib-0002){ref-type="ref"} However, the macrophage polarization involved in lanthanum clearance in the gastrointestinal tract has not been elucidated. We found that biopsy specimens from the stomach of 62‐year‐old man with diabetes mellitus, 2‐year history of dialysis, 9‐month history of LC administration, and no specific abnormal physical examination revealed massive eosinophilic infiltration positive for CD68 and CD206 (Figure [1](#ccr31989-fig-0001){ref-type="fig"}D). CD68 is a common and general marker for both M1 and M2 macrophages, while CD206 is a marker to indicate M2 polarization. Therefore, we assume that phagocytizing M2 macrophages play an important role and M2 polarity induction can accelerate the clearance of lanthanum.[2](#ccr31989-bib-0002){ref-type="ref"}

###### 

Previously reported cases of lanthanum carbonate deposition

  Authors      Year   Number of patients   Age      Co‐existing symptoms                                                    Duration of LC administration (mo)   Dose of LC (mg/d)   Deposition site        Immunohistochemistry
  ------------ ------ -------------------- -------- ----------------------------------------------------------------------- ------------------------------------ ------------------- ---------------------- ----------------------------
  Yasunaga     2015   1                    64       Epigastric discomfort                                                   50                                   1500                Stomach                CD68, S100, Cam 5.2
  Makino       2015   1                    63       Heartburn and hiccups                                                   41                                   500‐750             Stomach                CD68
  Haratake     2015   6                    61‐69    Abdominal discomfort and pain                                           21‐49                                500‐1500            Stomach and duodenum   CD68, S100, Cam 5.2, Ki‐67
  Rothenberg   2015   1                    64       Low‐grade fever, nausea, diarrhea, and anorexia                         NA                                   NA                  Stomach and duodenum   CD68, CAM5.2, CD1a, S100
  Tonooka      2015   1                    81       Abdominal discomfort                                                    7                                    750                 Stomach                NA
  Goto         2016   19                   NA       NA                                                                      NA                                   NA                  Stomach and colon      NA
  Yabuki       2016   3                    68‐77    None                                                                    3‐36                                 750‐1500            Stomach and duodenum   CD68
  Shitomi      2017   23                   34‐82    Nausea, melena, abdominal pain, and discomfort                          3‐67                                 500‐750             Stomach                CD68
  Hoda         2017   5                    29‐66    Dysphagia, reflux, nausea, epigastric burn, melena, and early satiety   12‐72                                3000‐6000           Stomach and duodenum   NA
  Murakami     2017   7                    50‐79    Difficulty swallowing and appetite loss                                 5‐45                                 NA                  Stomach                CD68
  Iwamuro      2017   2                    42, 73   None                                                                    25, 69                               NA                  Stomach and duodenum   CD68
  Hattori      2017   16                   47‐79    None                                                                    4‐65                                 500‐1500            Stomach and duodenum   CD68
  Nishikawa    2018   1                    64       Nausea                                                                  72                                   750‐1500            Stomach                NA
  Iwamuro      2018   10                   42‐76    NA                                                                      12‐86                                NA                  Stomach and duodenum   NA
  Eso          2018   1                    26       Epigastric discomfort and appetite loss                                 84                                   750                 Stomach and duodenum   CD68, PU.1
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![Lanthanum deposition and their analysis (A‐D). Lanthanum deposits are recognized as minute whitish granules within mucosa by endoscopy (A). They are also recognized as eosinophilic infiltration in the lamina propria with hematoxylin and eosin staining (B). Quantitative analysis of elemental composition by electron probe microanalysis reveals macrophages include both lanthanum and phosphorus (yellow area; C). Macrophages are positive for CD206, indicating M2 polarization (D)](CCR3-7-570-g001){#ccr31989-fig-0001}
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